Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study.
Aberer F, Pferschy PN, Tripolt NJ, Sourij C, Obermayer AM, Prüller F, Novak E, Reitbauer P, Kojzar H, Prietl B, Kofler S, Brunner M, Svehlikova E, Stojakovic T, Scharnagl H, Oulhaj A, Aziz F, Riedl R, Sourij H.
Aberer F, et al. Among authors: kofler s.
Diabetes Obes Metab. 2020 Feb;22(2):212-221. doi: 10.1111/dom.13889. Epub 2019 Nov 3.
Diabetes Obes Metab. 2020.
PMID: 31595635
Free PMC article.
Clinical Trial.